Borg J - Search Results

1

Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of life.

Sanmamed N, Chung P, Berlin A, Adleman J, Borg J, Lao B, Ghai S, Weersink R, Simeonov A, Rink A, Menard C, Helou J. Sanmamed N, et al. Among authors: borg j. Brachytherapy. 2019 Jul-Aug;18(4):477-483. doi: 10.1016/j.brachy.2019.02.003. Epub 2019 May 17. Brachytherapy. 2019. PMID: 31109872 Clinical Trial.

2

Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.

Saibishkumar EP, Borg J, Yeung I, Cummins-Holder C, Landon A, Crook JM. Saibishkumar EP, et al. Among authors: borg j. Brachytherapy. 2008 Apr-Jun;7(2):200-5. doi: 10.1016/j.brachy.2007.12.005. Epub 2008 Mar 24. Brachytherapy. 2008. PMID: 18362087

3

The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.

Patil N, Crook J, Saibishkumar EP, Aneja M, Borg J, Pond G, Ma C. Patil N, et al. Among authors: borg j. Brachytherapy. 2009 Apr-Jun;8(2):218-222. doi: 10.1016/j.brachy.2008.12.001. Epub 2009 Feb 20. Brachytherapy. 2009. PMID: 19230790

4

Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy.

Crook J, Patil N, Ma C, McLean M, Borg J. Crook J, et al. Among authors: borg j. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1079-84. doi: 10.1016/j.ijrobp.2009.06.040. Epub 2009 Oct 31. Int J Radiat Oncol Biol Phys. 2010. PMID: 19879700

5

The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy.

Piña AG, Crook JM, Kwan P, Borg J, Ma C. Piña AG, et al. Among authors: borg j. Brachytherapy. 2010 Jul-Sep;9(3):213-8. doi: 10.1016/j.brachy.2009.09.002. Epub 2009 Dec 22. Brachytherapy. 2010. PMID: 20022565

6

Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancer.

Gómez-Iturriaga Piña A, Crook J, Borg J, Lockwood G, Fleshner N. Gómez-Iturriaga Piña A, et al. Among authors: borg j. Urology. 2010 Jun;75(6):1412-6. doi: 10.1016/j.urology.2009.04.101. Epub 2009 Dec 29. Urology. 2010. PMID: 20035986

7

10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients.

Crook J, Borg J, Evans A, Toi A, Saibishkumar EP, Fung S, Ma C. Crook J, et al. Among authors: borg j. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1323-9. doi: 10.1016/j.ijrobp.2010.04.038. Epub 2010 Aug 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675072

8

Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90) ≥180 Gy.

Gómez-Iturriaga Piña A, Crook J, Borg J, Ma C. Gómez-Iturriaga Piña A, et al. Among authors: borg j. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):422-7. doi: 10.1016/j.ijrobp.2009.07.1723. Int J Radiat Oncol Biol Phys. 2010. PMID: 20832665

9

Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy.

Nasser NJ, Wang Y, Borg J, Saibishkumar EP. Nasser NJ, et al. Among authors: borg j. Brachytherapy. 2014 Jul-Aug;13(4):369-74. doi: 10.1016/j.brachy.2014.01.007. Epub 2014 Feb 20. Brachytherapy. 2014. PMID: 24559795

10

Dosimetric evaluation of clinical target volume in the postimplant analysis of low-dose-rate brachytherapy for prostate cancer.

Nasser NJ, Sappiatzer J, Wang Y, Borg J, Saibishkumar EP. Nasser NJ, et al. Among authors: borg j. Brachytherapy. 2015 Mar-Apr;14(2):189-96. doi: 10.1016/j.brachy.2014.08.044. Epub 2014 Oct 7. Brachytherapy. 2015. PMID: 25301338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

924 results

Search Page

Filters